Woodcock Again Voices Concern About New FDA Centers Of Excellence

Acting FDA chief Janet Woodcock again raised concerns about lawmakers’ push to create new centers of excellence at the agency, arguing that FDA first needs to be provided with more resources. She also noted that creating new centers of excellence can create organizational complications, as it would require FDA to be organized by product area as opposed to clinical area. The agency is critically under-staffed and financially constrained, Woodcock said in a pre-recorded interview posted online as part of Prevision...